about
Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality.The DOPPS Practice Monitor for US Dialysis Care: PTH Levels and Management of Mineral and Bone Disorder in US Hemodialysis Patients.The DOPPS practice monitor for US dialysis care: potential impact of recent guidelines and regulatory changes on management of mineral and bone disorder among US hemodialysis patients.Two-times weekly hemodialysis in China: frequency, associated patient and treatment characteristics and Quality of Life in the China Dialysis Outcomes and Practice Patterns study.Associations of self-reported physical activity types and levels with quality of life, depression symptoms, and mortality in hemodialysis patients: the DOPPS.Sex-specific differences in hemodialysis prevalence and practices and the male-to-female mortality rate: the Dialysis Outcomes and Practice Patterns Study (DOPPS).Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.Importance of simultaneous evaluation of multiple risk factors for hemodialysis patients' mortality and development of a novel index: dialysis outcomes and practice patterns studyPhosphate binder pill burden, patient-reported non-adherence, and mineral bone disorder markers: Findings from the DOPPSAnemia Management in the China Dialysis Outcomes and Practice Patterns StudyInternational Comparisons to Assess Effects of Payment and Regulatory Changes in the United States on Anemia Practice in Patients on Hemodialysis: The Dialysis Outcomes and Practice Patterns Study.Associations of frequency and duration of patient-doctor contact in hemodialysis facilities with mortality.Hemodialysis Facility Variation in Hospitalization and Transfusions Using Medicare Claims: The DOPPS Practice Monitor for US Dialysis Care.Initiation of Sevelamer and Mortality among Hemodialysis Patients Treated with Calcium-Based Phosphate Binders.Mineral bone disorder and its management among hemodialysis patients in the Gulf Cooperation Council: Initial findings from the dialysis outcomes and practice patterns study (2012-2015).Gulf Cooperation Council-dialysis outcomes and practice patterns study: An overview of anemia management trends at the regional and country specific levels in the Gulf Cooperation Council countries.Hemodialysis delivery, dialysis dose achievement, and vascular access types in hemodialysis patients from the Gulf Cooperation Council countries enrolled in the dialysis outcomes and practice patterns study phase 5 (2012-2015).Nutritional status and outcomes in hemodialysis patients from the Gulf Cooperation Council countries enrolled in the dialysis outcome and practice patterns study phase 5 (2012-2015).Cardiovascular and cerebrovascular comorbidities in hemodialysis patients from the Gulf Cooperation Council countries enrolled in the dialysis outcome and practice pattern study phase 5 (2012-2015).The dialysis outcomes and practice patterns study phase 5 in the Gulf Cooperation Council countries: Design and study methods.Mortality, Hospitalization, and Quality of Life among Patients with Hepatitis C Infection on Hemodialysis.Cardiovascular and Stroke Risk in Japanese Hemodialysis Patients With Atrial Fibrillation.Interdialytic Weight Gain: Trends, Predictors, and Associated Outcomes in the International Dialysis Outcomes and Practice Patterns Study (DOPPS).Hemodialysis practice patterns in the Russia Dialysis Outcomes and Practice Patterns Study (DOPPS), with international comparisons.The Dialysis Outcomes and Practice Patterns Study (DOPPS) in Turkey.Unique hemoglobin A1c level distribution and its relationship with mortality in diabetic hemodialysis patients.Functional Dependence and Mortality in the International Dialysis Outcomes and Practice Patterns Study (DOPPS).Understanding associations of hemodialysis practices with clinical and patient-reported outcomes: examples from the DOPPS.Hepatitis C infection is very rarely treated among hemodialysis patients.Evaluating the effectiveness of IV iron dosing for anemia management in common clinical practice: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).Implementation and first results of a German chronic kidney disease registry.International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on Hemodialysis.Geographical Variations in Blood Pressure Level and Seasonality in Hemodialysis Patients.Demographics and key clinical characteristics of hemodialysis patients from the Gulf Cooperation Council countries enrolled in the dialysis outcomes and practice patterns study phase 5 (2012-2015).Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS).Erythropoietin Hyporesponsiveness in Dialysis Patients: Possible Role of Statins.Twice-Weekly Hemodialysis and Clinical Outcomes in the China Dialysis Outcomes and Practice Patterns Study.Mineral and bone disorder management in hemodialysis patients: comparing PTH control practices in Japan with Europe and North America: the Dialysis Outcomes and Practice Patterns Study (DOPPS)Dialysis Outcomes and Practice Patterns Study (DOPPS): its strengths, limitations, and role in informing practices and policiesHemodialysis patients with hepatitis C infection are not receiving the new antiviral medications
P50
Q30839550-B7A28979-5B80-4843-ABF3-5414C7D65C5BQ33702417-CCBC9916-46DD-43C3-915C-B19E1D65AF38Q33725069-B33B30A6-0956-4F11-9A7A-D8C0CD82461BQ34137864-B08EFF87-A115-4E7C-81DE-9FC3B9DF2280Q34292935-18C11916-9B86-4AE7-967B-4186D4866BD1Q34414553-C5F568B8-5764-4486-9EDD-9A2A2AF9372FQ34828835-45B398E5-23D7-40BC-9F99-8B8A9A96ADBFQ35648040-C563D36C-18B1-43AE-8700-9A6A8F1684EBQ36279054-014BE75B-122E-4611-9487-8022162DC30AQ37033628-A87F4638-E701-433A-AB3A-561A32C575DFQ37052058-C25C24FA-2684-4D3B-B4D7-E94F26087CBBQ37119901-46308899-4F2F-4C18-93DE-71655ED18EEEQ38623838-D2DA356E-EE0B-4C13-9CF9-BEF2559964FCQ38671509-92464808-885D-46E0-8D8F-EDB7DE131BF2Q38780955-72E4762F-9896-42C6-84C7-472BE2D620C2Q39043028-27F6B9BD-73F3-42E9-B771-5D463F1EFDE6Q39089872-29944DA6-52BF-4184-BCF4-3A5E0B1F78FBQ39089876-4A83568E-6951-4101-91F3-A77126243A14Q39089879-197E7C52-7712-4469-899A-681A43945B07Q39089882-6A3A5871-F2ED-4E7E-BBD1-191850EE33B7Q39138199-0B96D024-6ABE-41F3-B0DC-2276BEDA551AQ39145892-BE29DA73-C31B-450C-859D-88F3750B032DQ39170702-10D3A549-B2F3-46F9-9A3A-4E71FFDBC05EQ39240109-FBDF9291-7D43-4C8A-8B1F-1D02E66BFA40Q39249486-AC0BFAEF-9988-4F2A-B7A3-F8792636E117Q40249413-A5812294-461E-49FF-9B03-8047D3188202Q40269289-2F6786B7-4CC5-4C39-93FC-99E7DC5D99D4Q40334822-AB7E961A-7170-423B-B1C6-7E1AEF19D20EQ42257638-2F658F1F-CC89-4940-9BEE-895E81269185Q44676908-AD5B0156-FC00-4029-BE15-CB975F4F62A0Q45134632-7358B96D-C067-4998-8410-4C6BB586DAD7Q47688794-52ACBCA7-8133-49B8-8083-7718EE28B68AQ49645051-85409117-4883-4050-9DAA-101F05D78D58Q52774830-1B2675B8-A3F6-44EE-9258-9DBD9E3E18F9Q53102532-9AB836E4-DA2D-40D7-9B30-7854DC1791B6Q53738394-13197826-2728-42EC-A176-A38EA3FD991EQ55474393-E2503BC2-0036-4285-9810-0241E340F19AQ57021200-A644B4A5-105C-4F52-AB5F-D8C0F504F5C8Q85275097-A7B49D5A-E8BF-4A83-91C2-2FC95D98FCB8Q85313853-F78F5647-AFD6-4AF0-80D3-102FDF7E3B57
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Brian Bieber
@ast
Brian Bieber
@en
Brian Bieber
@es
Brian Bieber
@nl
Brian Bieber
@sl
type
label
Brian Bieber
@ast
Brian Bieber
@en
Brian Bieber
@es
Brian Bieber
@nl
Brian Bieber
@sl
prefLabel
Brian Bieber
@ast
Brian Bieber
@en
Brian Bieber
@es
Brian Bieber
@nl
Brian Bieber
@sl
P106
P21
P31
P496
0000-0001-8505-0979